A method of utrophin up-regulation through RNAi-mediated knockdown of the transcription factor EN1

Journal of International Medical Research

Volumn 39, Issue 1, 2011, Pages 161-171

  Wang, Q ^a   Cao, D H ^b   Jin, C L ^a   Lin, C K ^a   Ma, H W ^a   Wu, Y Y ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b No 202 Hospital of PLA   (China)

Author keywords

Duchenne muscular dystrophy; ; EN1; Promoter; RNA interefernce; Up regulation; Utrophin

Indexed keywords

DYSTROPHIN; ENGRAILED 1 PROTEIN; HOMEODOMAIN PROTEIN; MESSENGER RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; UTROPHIN;

ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; ENZYME INHIBITION; GENE EXPRESSION; GENE SILENCING; HELA CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RHABDOMYOSARCOMA; RNA INTERFERENCE; UPREGULATION;

EID: 79952966003     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001103900117     Document Type: Article

References (44)

1. Pikó H, Nagy B, Balog J, et al: Carrier detection in families affected by Duchenne/Becker muscular dystrophy. Orv Hetil 2007; 148: 2403-2409
2. Liu H, Wang H, Lu Z, et al: A novel oligonucleotide arrays-based multiplex amplifiable probe hybridization technology. Yi 5 Chuan Xue Bao 2004; 31: 119-124 [in Chinese].
3. Chandrasekharan K, Yoon JH, Xu Y, et al: A human-specific deletion in mouse Cmah 6 increases disease severity in the mdx model of Duchenne muscular dystrophy. Sci Transl Med 2010; 2: 42-54.
4. Royuela M, Chazalette D, Hugon G, et al: Formation of multiple complexes between beta- dystroglycan and dystrophin family products. J Muscle Res Cell Motil 2003; 24: 387-397.
5. Ahn AH, Kunkel LM: The structural and functional diversity of dystrophin. Nat Genet 1993; 3: 283-291.
6. Tinsley JM, Blake DJ, Zuellig RA, et al: Increasing complexity of the dystrophin- associated protein complex. Proc Natl Acad Sci USA 1994; 91: 8307-8313.
7. Hack AA, Groh ME, McNally EM: Sarcoglycans in muscular dystrophy. Microsc Res Tech 2000; 48: 167-180.
8. Le Rumeur E, Winder SJ, Hubert JF: Dystrophin: more than just the sum of its parts. Biochim Biophys Acta 2010; 1804: 1713-1722.
9. Pilgram GS, Potikanond S, Baines RA, et al: The roles of the dystrophin-associated glycoprotein complex at the synapse. Mol Neurobiol 2010; 41: 1-21.
10. Neuman S, Kaban A, Volk T, et al: The dystrophin/utrophin homologues in Drosophila and in sea urchin. Gene 2001; 263: 17-29.
11. Perkins KJ, Davies KE: The role of utrophin in the potential therapy of Duchenne muscular dystrophy. Neuromuscul Disord 2002; 12(suppl 1): S78-S89.
12. Haenggi T, Schaub MC, Fritschy JM: Molecular heterogeneity of the dystrophin-associated protein complex in the mouse kidney nephron: differential alterations in the absence of utrophin and dystrophin. Cell Tissue Res 2005; 319: 299-313.
13. Matsumura K, Ervasti JM, Ohlendieck K, et al: Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle. Nature 1992; 360: 588-591.
14. Helliwell TR, Man NT, Morris GE, et al: The dystrophin-related protein, utrophin, is expressed on the sarcolemma of regenerating human skeletal muscle fibres in dystrophies and inflammatory myopathies. Neuromuscul Disord 1992; 2: 177-184.
15. Di Certo MG, Corbi N, Strimpakos G, et al: The artificial gene Jazz, a transcriptional regulator of utrophin, corrects the dystrophic pathology in mdx mice. Hum Mol Genet 2010; 19: 752-760.
16. Rigoletto C, Prelle A, Ciscato P, et al: Utrophin expression during human fetal development. Int J Dev Neurosci 1995; 13: 585-593.
17. Desantis A, Onori A, Di Certo MG, et al: Novel activation domain derived from Che-1 cofactor coupled with the artificial protein Jazz drives utrophin upregulation. Neuromuscul Disord 2009; 19: 158-162.
18. Yoon JH, Chandrasekharan K, Xu R, et al: The synaptic CT carbohydrate modulates binding and expression of extracellular matrix proteins in skeletal muscle: partial dependence on utrophin. Mol Cell Neurosci 2009; 41: 448-463.
19. Shaw CA, Larochelle N, Dudley RW, et al: Simultaneous dystrophin and dysferlin deficiencies associated with high-level expression of the coxsackie and adenovirus receptor in transgenic mice. Am J Pathol 2006; 169: 2148-2160.
20. Wang Q, L-LJ, Lin C, et al: Characteristics of dystrophin gene mutations among Chinese patients as revealed by multiplex ligation- dependent probe amplification. Genet Test Mol Biomarkers 2009; 13: 23-30.
21. Park KS, Oh D: Gene therapy for muscular dystrophies: progress and challenges. J Clin Neurol 2010; 6: 111-116.
22. Perkins KJ, Basu U, Budak MT, et al: Ets-2 repressor factor silences extrasynaptic utrophin by N-box mediated repression in skeletal muscle. Mol Biol Cell 2007; 18: 2864-2872.
23. Minetti GC, Colussi C, Adami R, et al: Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. Nat Med 2006; 12: 1147-1150.
24. Briguet A, Bleckmann D, Bettan M, et al: Transcriptional activation of the utrophin promoter B by a constitutively active Ets- transcription factor. Neuromuscul Disord 2003; 13: 143-150.
25. Baby SM, Bogdanovich S, Willmann G, et al: Differential expression of utrophin-A and -B promoters in the central nervous system (CNS) of normal and dystrophic mdx mice. Brain Pathol 2010; 20: 323-342.
26. Chakkalakal JV, Miura P, Belanger G, et al: Modulation of utrophin A mRNA stability in fast versus slow muscles via an AU-rich element and calcineurin signaling. Nucleic Acids Res 2008; 36: 826-838.
27. Auda-Boucher G, Rouaud T, Lafoux A, et al: Fetal muscle-derived cells can repair dystrophic muscles in mdx mice. Exp Cell Res 2007; 313: 997-1007.
28. Wang B, Li J, Fu FH, et al: Systemic human minidystrophin gene transfer improves functions and life span of dystrophin and dystrophin/utrophin-deficient mice. J Orthop Res 2009; 27: 421-426.
29. Li D, Long C, Yue Y, et al: Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice. Hum Mol Genet 2009; 18: 1209-1220.
30. Bogdanovich S, Perkins KJ, Krag TO, et al: Therapeutics for Duchenne muscular dystrophy: current approaches and future directions. J Mol Med 2004; 82: 102-115.
31. Rodova M, Brownback K, Werle MJ: Okadaic acid augments utrophin in myogenic cells. Neurosci Lett 2004; 363: 163-167.
32. Logan C, Hanks MC, Noble-Topham S, et al: Cloning and sequence comparison of the mouse, human, and chicken engrailed genes reveal potential functional domains and regulatory regions. Dev Genet 1992; 13: 345-358.
33. Gebelein B, Mann RS: Compartmental modulation of abdominal Hox expression by engrailed and sloppy-paired patterns the fly ectoderm. Dev Biol 2007; 308: 593-605.
34. Hanks MC, Loomis CA, Harris E, et al: Drosophila engrailed can substitute for mouse Engrailed1 function in mid-hindbrain, but not limb development. Development 1998; 125: 4521-4530.
35. Cheng Y, Sudarov A, Szulc KU, et al: The Engrailed homeobox genes determine the different foliation patterns in the vermis and hemispheres of the mammalian cerebellum. Development 2010; 137: 519-529.
36. Logan C, Willard HF, Rommens JM, et al: Chromosomal localization of the human homeo box-containing genes, EN1 and EN2. Genomics 1989; 4: 206-209.
37. Dennis CL, Tinsley JM, Deconinck AE, et al: Molecular and functional analysis of the utrophin promoter. Nucleic Acids Res 1996; 24: 1646-1652.
38. Davis RL, Weintraub H, Lassar AB: Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987; 51: 987-1000.
39. Lee JH, Bugarija B, Millan EJ, et al: Systematic identification of cis-silenced genes by trans complementation. Hum Mol Genet 2009; 18: 835-846.
40. Ali SA, Zaidi SK, Dacwag CS, et al: Phenotypic transcription factors epigenetically mediate cell growth control. Proc Natl Acad Sci USA 2008; 105: 6632-6637.
41. Tan X, Zhang Y, Zhang PJ, et al: Molecular structure and expression patterns of flounder (Paralichthys olivaceus) Myf-5, a myogenic regulatory factor. Comp Biochem Physiol B Biochem Mol Biol 2006; 145: 204-213.
42. Tsunemoto K, Anzai M, Matsuoka T, et al: Cis- acting elements (E-box and NBE) in the promoter region of three maternal genes (Histone H1oo, Nucleoplasmin 2, and Zygote Arrest 1) are required for oocyte-specific gene expression in the mouse. Mol Reprod Dev 2008; 75: 1104-1108.
43. Tanihata J, Suzuki N, Miyagoe-Suzuki Y, et al: Downstream utrophin enhancer is required for expression of utrophin in skeletal muscle. J Gene Med 2008; 10: 702-713.
44. Koike S, Schaeffer L, Changeux JP: Identification of a DNA element determining synaptic expression of the mouse acetylcholine receptor δ-subunit gene. Proc Natl Acad Sci USA 1995; 92: 10624-10628.